Virtual Reality: Distraction During Small Bore Intercostal Chest Drain Insertion
Launched by NATIONAL UNIVERSITY OF MALAYSIA · Jan 30, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of virtual reality (VR) as a way to distract patients during a procedure called intercostal chest drain (ICC) insertion. This procedure is commonly done to remove fluid, blood, or air from around the lungs, which can be caused by various medical conditions. The trial aims to see if using VR can help make this procedure more comfortable for patients by reducing anxiety or discomfort.
To participate in the trial, individuals must be undergoing an ICC insertion and be able to understand and give consent. However, people who are on sedative medications, have certain medical conditions, or have trouble wearing a VR device will not be eligible. Participants can expect to wear a VR headset during the procedure, which may help distract them and improve their overall experience. This trial is currently looking for volunteers and is open to all genders and ages.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants undergoing ICC insertion
- • Participants who could understand and give consent
- • Exclusion Criteria
- • Participants who are unable to understand or give consent
- • Ventilated patients
- • Participants who are not comfortable wearing VR device
- • Participants who are unable to communicate (illiterate, had hearing impairment, mute, blind or had memory impairment)
- • Participants with craniofacial deformity
- • Participants who are on sedative medication
- • Traumatic or post Motor Vehicular Accident patient Participants undergoing Indwelling pleural catheter insertion Participants with anxiety disorder
- Exclusion Criteria:
- • -
About National University Of Malaysia
The National University of Malaysia (Universiti Kebangsaan Malaysia, UKM) is a prestigious institution dedicated to advancing medical research and clinical trials that contribute significantly to the fields of healthcare and biomedical sciences. As a leading academic and research university, UKM is committed to fostering innovation and excellence in clinical research, promoting collaboration among multidisciplinary teams, and enhancing the quality of patient care. The university's robust infrastructure and experienced research faculty facilitate rigorous clinical trials aimed at addressing critical health challenges, thereby improving health outcomes both locally and globally. Through its dedication to ethical research practices and adherence to regulatory standards, UKM strives to enhance the understanding of diseases and develop effective interventions that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, Wilayah Persekutuan, Malaysia
Patients applied
Trial Officials
Mohamed Faisal Abdul Hamid, MBBS (IIUM)
Principal Investigator
National University of Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported